Leeds surgeons complete first-in-human knee reconstruction with OsStic synthetic bone material

Leeds surgeons complete first-in-human knee reconstruction with OsStic synthetic bone material

Latest Medtech News


Researchers and surgeons at Leeds Teaching Hospitals NHS Trust and the University of Leeds have used a new synthetic bone repair material, OsStic, in what they describe as a world-first knee reconstruction. The first-in-human procedure treated a patient with a complex lateral tibial plateau fracture, a split depression injury to the top of the shinbone that is hard to reconstruct and can leave lasting effects on mobility.

As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.

OsStic, developed by Biomimetic Innovations Ltd, an affiliate of PBC Biomed, is injected into gaps and weakened areas within bone. It fills them and supports the bone while encouraging the body to grow new bone. The study is funded by Biomimetic Innovations and supported by the NIHR Clinical Research Facility: Leeds, and led by Professor Peter Giannoudis.

The surgical team rebuilt the damaged joint and restored its structural integrity, and the patient continued rehabilitation at home one day after surgery, which Giannoudis called extremely encouraging. This is a single patient, and the procedure is the first step in the trial.

For Biomimetic Innovations, it is the first human use of OsStic, a material that already holds FDA Breakthrough Device designation. For the broader MedTech space, it adds a new option to the toolkit for complex fracture repair, an area where conventional fixation can have limits. Paul Burke, the company’s Managing Partner, called it a major milestone.

Go Back

We'd love to hear what you're building